Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 182,665,312
  • Shares Outstanding, K 1,240,680
  • Annual Sales, $ 28,754 M
  • Annual Income, $ 480,000 K
  • EBIT $ 10,490 M
  • EBITDA $ 13,257 M
  • 60-Month Beta 0.36
  • Price/Sales 6.39
  • Price/Cash Flow 22.08
  • Price/Book 8.77

Options Overview Details

View History
  • Implied Volatility 28.99% (-5.83%)
  • Historical Volatility 33.14%
  • IV Percentile 45%
  • IV Rank 26.46%
  • IV High 49.97% on 04/08/25
  • IV Low 21.43% on 02/12/25
  • Expected Move (DTE 2) 3.45 (2.22%)
  • Put/Call Vol Ratio 0.70
  • Today's Volume 18,006
  • Volume Avg (30-Day) 12,825
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 177,753
  • Open Int (30-Day) 154,719
  • Expected Range 152.35 to 159.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.90
  • Number of Estimates 4
  • High Estimate 2.05
  • Low Estimate 1.69
  • Prior Year 1.81
  • Growth Rate Est. (year over year) +4.97%

Price Performance

See More
Period Period Low Period High Performance
1-Month
119.63 +30.23%
on 01/12/26
157.29 -0.95%
on 02/11/26
+34.70 (+28.65%)
since 01/09/26
3-Month
116.88 +33.30%
on 01/05/26
157.29 -0.95%
on 02/11/26
+33.24 (+27.12%)
since 11/11/25
52-Week
93.37 +66.86%
on 04/25/25
157.29 -0.95%
on 02/11/26
+59.66 (+62.06%)
since 02/11/25

Most Recent Stories

More News
Stocks Settle Mixed as Fed Rate Cut Chances Slip

The S&P 500 Index ($SPX ) (SPY ) closed unchanged on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.29%. March E-mini...

MSTR : 126.07 (-5.21%)
LSCC : 105.77 (+16.29%)
ADI : 337.00 (+3.64%)
GLXY : 20.40 (-3.73%)
COIN : 153.20 (-5.73%)
STX : 407.25 (+2.78%)
WDC : 273.74 (+4.26%)
VRT : 248.51 (+24.49%)
^BTCUSD : 67,519.82 (-0.45%)
SPY : 691.96 (-0.02%)
ADSK : 232.59 (-4.51%)
MU : 410.34 (+9.94%)
Stocks Turn Mixed as Software Stocks Slide

The S&P 500 Index ($SPX ) (SPY ) today is down -0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.10%. March E-mini S&P futures (ESH26...

AMAT : 339.88 (+3.29%)
MAT : 15.80 (-24.98%)
INTU : 399.69 (-5.15%)
LSCC : 105.77 (+16.29%)
ADI : 337.00 (+3.64%)
DDOG : 127.33 (-1.80%)
RPD : 7.38 (-28.97%)
TXN : 226.56 (+2.55%)
$IUXX : 25,201.26 (+0.29%)
ZNH26 : 112-090 (unch)
MSFT : 404.37 (-2.15%)
TDC : 37.88 (+29.59%)
GILD Q4 Deep Dive: HIV Prevention and Oncology Advances Drive Mixed Outlook

GILD Q4 Deep Dive: HIV Prevention and Oncology Advances Drive Mixed Outlook

GILD : 155.80 (+5.82%)
Gilead Sciences’s (NASDAQ:GILD) Q4 CY2025 Sales Beat Estimates

Gilead Sciences’s (NASDAQ:GILD) Q4 CY2025 Sales Beat Estimates

GILD : 155.80 (+5.82%)
Gilead: Q4 Earnings Snapshot

Gilead: Q4 Earnings Snapshot

GILD : 155.80 (+5.82%)
Gilead Sciences Announces 3.8 Percent Increase in First Quarter 2026 Dividend

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 3.8% in the company’s quarterly cash dividend, beginning in the first quarter...

GILD : 155.80 (+5.82%)
Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results

Product Sales Excluding Veklury Increased 4% Year-Over-Year to $28.0 billion for Full Year 2025 Biktarvy Sales Increased ...

GILD : 155.80 (+5.82%)
Stock Index Futures Muted With U.S. Retail Sales Data in Focus

March S&P 500 E-Mini futures (ESH26) are up +0.03%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.04% this morning, taking a breather after a recent rally as investors await a slew of U.S. economic...

META : 668.69 (-0.30%)
APP : 456.81 (-3.41%)
CVS : 77.02 (+1.74%)
THULE.S.DX : 240.000 (-2.28%)
AVGO : 342.76 (+0.68%)
KO : 78.60 (+2.33%)
CRDO : 128.40 (-4.69%)
F : 13.85 (+2.06%)
UPWK : 14.50 (-4.64%)
ESH26 : 6,962.00 (+0.02%)
KER.FP : 279.700 (-2.88%)
BP-.LN : 472.750 (+5.44%)
Stocks Set for Muted Open as Bond Yields Climb, Key U.S. Economic Data Awaited

March S&P 500 E-Mini futures (ESH26) are down -0.03%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.19% this morning, pointing to a muted open on Wall Street as rising Treasury yields curbed...

MSTR : 126.07 (-5.21%)
AMAT : 339.88 (+3.29%)
APP : 456.81 (-3.41%)
CVS : 77.02 (+1.74%)
ANET : 140.66 (-1.94%)
CSCO : 85.54 (-0.87%)
F : 13.85 (+2.06%)
HIMS : 16.69 (-3.19%)
SHOP : 118.71 (-6.70%)
NQH26 : 25,259.25 (-0.12%)
BILL : 47.02 (-7.09%)
ON : 71.18 (+5.64%)
U.S. Inflation, Retail Sales Due Next Week

Monday U.S. Featured Earnings Apollo Global Management (NYSE: APO) (Q3) EPS of $1.91, ...

APO : 126.95 (-4.14%)
AMAT : 339.88 (+3.29%)
DE : 612.69 (+3.25%)
CSCO : 85.54 (-0.87%)
KO : 78.60 (+2.33%)
MCD : 323.21 (-0.85%)
TMUS : 209.54 (+5.07%)
ESNT : 65.51 (+1.98%)
BDX : 180.62 (+5.21%)
ACGL : 98.61 (+0.78%)
SPGI : 390.76 (-2.57%)
GILD : 155.80 (+5.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya,...

See More

Key Turning Points

3rd Resistance Point 169.51
2nd Resistance Point 163.40
1st Resistance Point 159.60
Last Price 155.80
1st Support Level 149.69
2nd Support Level 143.58
3rd Support Level 139.78

See More

52-Week High 157.29
Last Price 155.80
Fibonacci 61.8% 132.87
Fibonacci 50% 125.33
Fibonacci 38.2% 117.79
52-Week Low 93.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar